• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

IFITM3 and type I interferons are important for the control of influenza A virus replication in murine macrophages

tetano

Editor, Senior Moderator
Virology. 2019 Nov 5;540:17-22. doi: 10.1016/j.virol.2019.11.003. [Epub ahead of print] [h=1]IFITM3 and type I interferons are important for the control of influenza A virus replication in murine macrophages.[/h]
Londrigan SL[SUP]1[/SUP], Wakim LM[SUP]2[/SUP], Smith J[SUP]2[/SUP], Haverkate AJ[SUP]2[/SUP], Brooks AG[SUP]2[/SUP], Reading PC[SUP]3[/SUP].
[h=3]Author information[/h] 1 Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Victoria, 3000, Australia. Electronic address: sarahll@unimelb.edu.au. 2 Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Victoria, 3000, Australia. 3 Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Victoria, 3000, Australia; WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Diseases Reference Laboratory, The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Victoria, 3000, Australia.

[h=3]Abstract[/h] Abortive infection of macrophages serves as a "dead end" for most seasonal influenza A virus (IAV) strains, and it is likely to contribute to effective host defence. Interferon (IFN)-induced transmembrane protein 3 (IFITM3) restricts the early stages of IAV replication in epithelial cells, but IFITM3 restriction of IAV replication in macrophages has not been previously investigated. Herein, macrophages isolated from IFITM3-deficient mice were more susceptible to initial IAV infection, but late-stage viral replication was still controlled through abortive infection. Strikingly, IFNα/β receptor (IFNAR)-deficient macrophages infected with IAV were not only more susceptible to initial infection, but these cells also supported productive viral replication. Significantly, we have established that abortive IAV infection in macrophages is controlled through a type I IFN-dependent mechanism, where late-stage IAV replication can proceed in the absence of type I IFN responses. These findings provide novel mechanistic insight into macrophage-specific processes that potently shut down IAV replication.
Copyright ? 2019. Published by Elsevier Inc.


[h=4]KEYWORDS:[/h] IFITM3; Influenza; Interferon stimulated genes; Macrophages; Type I interferon; Viral restriction factors

PMID: 31731106 DOI: 10.1016/j.virol.2019.11.003
 
Back
Top Bottom